<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I1</bold>). Compound methyl 4-(4-(1H-indol-3-yl)butanamido)benzoate (I1a) (0.34 g, 1.0 mmol) was dissolved in 14 ml of NH
 <sub>2</sub>OK (0.56 g, 24 mmol) methanol solution. After 2 h, the solvent was evaporated under vacuum. The residue was acidified with saturated citric acid, and then extracted with EtOAc (3 × 20 ml). The organic layers were combined, washed with brine (3 × 20 ml) and dried over MgSO
 <sub>4</sub>. The desired compound 
 <bold>c</bold> (0.16 g, 46% yield) was derived by crystallisation in EtOAc as white powder. HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>19</sub>H
 <sub>20</sub>N
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 338.14600, found 338.34195. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.08 (s, 1H), 10.78 (s, 1H), 10.09 (s, 1H), 8.93 (s, 1H), 7.68 (dd, 
 <italic>J</italic> = 18.4, 8.8 Hz, 4H), 7.53 (d, 
 <italic>J</italic> = 7.8 Hz, 1H), 7.34 (d, 
 <italic>J</italic> = 8.0 Hz, 1H), 7.14 (s, 1H), 7.08–7.04 (m, 1H), 6.99–6.95 (m, 1H), 2.74 (t, 
 <italic>J</italic> = 7.36 Hz, 2H), 2.40 (t, 
 <italic>J</italic> = 7.4 Hz, 2H), 2.01–1.94 (m, 2H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.14, 164.46, 142.34, 136.79, 128.12, 127.63, 127.38, 122.80, 121.32, 118.77, 118.61, 114.42, 111.81, 36.66, 26.25, 24.73 ppm.
</p>
